2018 Feb/Mar;80(2):141-153
Individual response to GLP-1 medications varies meaningfully variants in GLP1R (the GLP-1 receptor itself), GIPR (which matters specifically for tirzepatide's dual-agonist mechanism), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with different weight-loss curves and different tolerability profiles
The mechanism through which soluble fiber impacts GLP-1 production is both fascinating and fundamental to our understanding of metabolic health
The TrimRx Approach to Personalized Weight Loss and Health At TrimRx, we believe that effective health management, particularly for weight loss and related conditions, thrives on personalization and support
While there are steps you can take after ceasing these medications that may help reduce your risk of regaining weight, health experts say that a persons best bet for maintaining weight loss while taking drugs like Ozempic is to take the medication long-term.